Southpoint Capital Advisors LP 13D and 13G filings for Fennec Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-14 5:00 pm Sale | 2025-12-31 | 13G | FENNEC PHARMACEUTICALS, INC. O FENC | Southpoint Capital Advisors LP | 2,744,741 8.000% | -1,332,473 (-32.68%) | Filing |